BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18247504)

  • 1. Copper(II) ion binding to cellular prion protein.
    Zidar J; Pirc ET; Hodoscek M; Bukovec P
    J Chem Inf Model; 2008 Feb; 48(2):283-7. PubMed ID: 18247504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raman spectroscopic study on the copper(II) binding mode of prion octapeptide and its pH dependence.
    Miura T; Hori-i A; Mototani H; Takeuchi H
    Biochemistry; 1999 Aug; 38(35):11560-9. PubMed ID: 10471308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion protein selectively binds copper(II) ions.
    Stöckel J; Safar J; Wallace AC; Cohen FE; Prusiner SB
    Biochemistry; 1998 May; 37(20):7185-93. PubMed ID: 9585530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper reduction by the octapeptide repeat region of prion protein: pH dependence and implications in cellular copper uptake.
    Miura T; Sasaki S; Toyama A; Takeuchi H
    Biochemistry; 2005 Jun; 44(24):8712-20. PubMed ID: 15952778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein.
    Hornshaw MP; McDermott JR; Candy JM
    Biochem Biophys Res Commun; 1995 Feb; 207(2):621-9. PubMed ID: 7864852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the pathological Q212P mutation on human prion protein non-octarepeat copper-binding site.
    D'Angelo P; Della Longa S; Arcovito A; Mancini G; Zitolo A; Chillemi G; Giachin G; Legname G; Benetti F
    Biochemistry; 2012 Aug; 51(31):6068-79. PubMed ID: 22788868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermodynamic and voltammetric characterization of the metal binding to the prion protein: insights into pH dependence and redox chemistry.
    Davies P; Marken F; Salter S; Brown DR
    Biochemistry; 2009 Mar; 48(12):2610-9. PubMed ID: 19196019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Yin-Yang role for metals in prion disease.
    Wong BS; Brown DR; Sy MS
    Panminerva Med; 2001 Dec; 43(4):283-7. PubMed ID: 11677424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and stability of the CuII complexes with tandem repeats of the chicken prion.
    Stanczak P; Valensin D; Juszczyk P; Grzonka Z; Migliorini C; Molteni E; Valensin G; Gaggelli E; Kozlowski H
    Biochemistry; 2005 Oct; 44(39):12940-54. PubMed ID: 16185063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single particle analysis of manganese-induced prion protein aggregates.
    Levin J; Bertsch U; Kretzschmar H; Giese A
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1200-7. PubMed ID: 15766554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion disease: A loss of antioxidant function?
    Wong BS; Pan T; Liu T; Li R; Petersen RB; Jones IM; Gambetti P; Brown DR; Sy MS
    Biochem Biophys Res Commun; 2000 Aug; 275(2):249-52. PubMed ID: 10964653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper binding to prion octarepeat peptides, a combined metal chelate affinity and immunochemical approaches.
    Todorova-Balvay D; Simon S; Créminon C; Grassi J; Srikrishnan T; Vijayalakshmi MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(1):75-82. PubMed ID: 15722047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and dynamic characterization of copper(II) binding of the human prion protein outside the octarepeat region.
    Berti F; Gaggelli E; Guerrini R; Janicka A; Kozlowski H; Legowska A; Miecznikowska H; Migliorini C; Pogni R; Remelli M; Rolka K; Valensin D; Valensin G
    Chemistry; 2007; 13(7):1991-2001. PubMed ID: 17152102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper binding to chicken and human prion protein amylodogenic regions: differences and similarities revealed by Ni2+ as a diamagnetic probe.
    Valensin D; Gajda K; Gralka E; Valensin G; Kamysz W; Kozlowski H
    J Inorg Biochem; 2010 Jan; 104(1):71-8. PubMed ID: 19883942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of copper(II) with the prion peptide fragment HuPrP(76-114) encompassing four histidyl residues within and outside the octarepeat domain.
    Di Natale G; Osz K; Nagy Z; Sanna D; Micera G; Pappalardo G; Sóvágó I; Rizzarell E
    Inorg Chem; 2009 May; 48(9):4239-50. PubMed ID: 19348438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The configuration of the Cu(2+) binding region in full-length human prion protein compared with the isolated octapeptide.
    Weiss A; Del Pino P; Bertsch U; Renner C; Mentler M; Grantner K; Moroder L; Kretzschmar HA; Parak FG
    Vet Microbiol; 2007 Aug; 123(4):358-66. PubMed ID: 17482774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion protein fate governed by metal binding.
    Tsenkova RN; Iordanova IK; Toyoda K; Brown DR
    Biochem Biophys Res Commun; 2004 Dec; 325(3):1005-12. PubMed ID: 15541389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The amyloidogenic region of the human prion protein contains a high affinity (Met)(2)(His)(2) Cu(I) binding site.
    Badrick AC; Jones CE
    J Inorg Biochem; 2009 Aug; 103(8):1169-75. PubMed ID: 19615751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometric determination of the coordination geometry of potential copper(II) surrogates for the mammalian prion protein octarepeat region.
    Pushie MJ; Ross AR; Vogel HJ
    Anal Chem; 2007 Aug; 79(15):5659-67. PubMed ID: 17608450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper(II) coordination outside the tandem repeat region of an unstructured domain of chicken prion protein.
    Gralka E; Valensin D; Gajda K; Bacco D; Szyrwiel L; Remelli M; Valensin G; Kamasz W; Baranska-Rybak W; Kozłowski H
    Mol Biosyst; 2009 May; 5(5):497-510. PubMed ID: 19381364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.